Hospitals Cry Foul After Eli Lilly Withholds 340B Discounts
Eli Lilly made good on its threat to withhold 340B drug discounts from hospitals that refused to submit claims data. Hospital groups are calling the policy unlawful, arguing that the company has no legal authority to create its own compliance requirements for a federal program.
Abarca Health and LucyRx to Combine to Scale Independent PBM Model
Abarca Health and LucyRx plan to combine to build a larger independent PBM serving more than 9 million members.
Alternative Health Plan Designs Are Reshaping Employer Benefits
Alternative health plan designs represent much more than a passing trend. They are actively testing long-standing assumptions about how benefits should be structured, delivered, and experienced.
Passive Immunization: The Expanding Role of Monoclonal Antibodies in Preventive Medicine
For governments and health systems, monoclonal antibodies represent not just another drug class, but a strategic shift toward precision prevention.
Preparing Healthcare Networks For The Vulnerability Flood
We’re entering uncharted territory if bad actors can both launch zero-days and exploit unaddressed backdoors with new efficiency. This is why teams need to unify their network structure and better forecast what they’re up against.